...
首页> 外文期刊>Applied Spectroscopy: Society for Applied Spectroscopy >Evaluation of Transmission and Reflection Modalities for Measuring Content Uniformity of Pharmaceutical Tablets with Near-Infrared Spectroscopy
【24h】

Evaluation of Transmission and Reflection Modalities for Measuring Content Uniformity of Pharmaceutical Tablets with Near-Infrared Spectroscopy

机译:评估近红外光谱法测定药物片剂含量均匀性的透射和反射模态

获取原文
获取原文并翻译 | 示例
           

摘要

This paper examines how one may assess spectral changes with instrument configuration (or composition), in combination with the spectral changes in the measurement that are caused by experimental effects, and subsequently select an appropriate measurement modality for tablet content uniformity determination with near-infrared (NIR) spectroscopy. Two NIR spectrometers furnished with three configurations in the sample measurement interface were evaluated. One spectrometer, Bruker MPA (multiple purpose analyzer), was equipped with two measurement modalities, diffuse transmission (DT) and diffuse reflection based on integrating sphere optics (DR/IS). The other spectrometer, Bruker StepOne, was equipped only with diffuse reflection mode based on a fiber-optic probe (DR/FO). The data were collected with each of the configurations for the tablets associated with two dosage strengths differing significantly in diameter and thickness. Spectral diagnosis was performed in terms of sensitivity and selectivity. The signal-to-noise ratio computed for the data collected with the DT and DR/IS spectrometers was approximately an order of magnitude greater than that computed for the DR/FO spectrometer. The net-analyte-signal-based selectivity analysis of NIR spectra associated with the sample tablet and the placebo tablet indicated that both transmission and reflection mode provided similar selectivity when the optimal spectral range was chosen. A partial least squares (PLS) calibration model was developed for each data set. The overall standard error of calibration for each DT and DR/IS measurement was approximately 0.3percent in weight for each strength, significantly better than the value of 1.0percent in weight produced by the DR/FO measurement. This result was consistent with the sensitivity analysis based on spectral noise characterization. The poor analytical performance of the DR/FO spectrometer was attributed to the small illumination spot size of the reflection probe and thus the sensitivity of the measurements to the tablet engraving. The PLS analysis and spectral diagnostics both showed that transmission and reflection modes based on the Bruker MPA provided similar measurement accuracy for each strength. However, the robustness study clearly revealed that the transmission mode would be more robust than the reflection mode when there is considerable variability in the chemical composition and physical properties of tablets.
机译:本文探讨了如何评估仪器配置(或成分)的光谱变化以及由实验效应引起的测量光谱变化,然后选择一种合适的测量方式用于近红外(近红外光谱。评估了两个在样品测量界面中配备三种配置的NIR光谱仪。一种光谱仪Bruker MPA(多用途分析仪)配备了两种测量模式,即基于积分球光学系统(DR / IS)的漫透射(DT)和漫反射。另一个光谱仪Bruker StepOne仅配备了基于光纤探头(DR / FO)的漫反射模式。使用与直径和厚度明显不同的两种剂量强度有关的片剂的每种构型收集数据。根据灵敏度和选择性进行光谱诊断。用DT和DR / IS光谱仪收集的数据计算出的信噪比大约比DR / FO光谱仪计算的信噪比高一个数量级。基于净分析物信号的与样品片剂和安慰剂片剂相关的NIR光谱的选择性分析表明,当选择最佳光谱范围时,透射和反射模式均提供相似的选择性。为每个数据集开发了偏最小二乘(PLS)校准模型。每种DT和DR / IS测量的校准总标准误差约为每种强度的0.3%(重量),明显好于DR / FO测量产生的1.0%(重量)的值。该结果与基于频谱噪声表征的灵敏度分析一致。 DR / FO光谱仪的较差的分析性能归因于反射探头的照明光斑尺寸小,因此测量值对药片雕刻的敏感性。 PLS分析和光谱诊断均表明,基于Bruker MPA的透射和反射模式可为每种强度提供相似的测量精度。但是,健壮性研究清楚地表明,当片剂的化学成分和物理特性存在较大差异时,透射模式将比反射模式更健壮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号